ahlam1399
07-27-2015, 11:38 AM
AstraZeneca sells rare cancer drug to Sa**fi for up $300 million
LONDON (Reuters) - AstraZeneca, under pressure from falling sales of older *****, is selling a medicine for a rare type of cancer to Sa**fi as it continues a drive to raise cash by divesting certain assets.
http://rc.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/rc/1/rc.img (http://rc.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/rc/1/rc.htm)
http://rc.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/rc/2/rc.img (http://rc.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/rc/2/rc.htm)
http://rc.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/rc/3/rc.img (http://rc.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/rc/3/rc.htm)
http://da.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/a2.img (http://da.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/a2.htm)
http://adchoice.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/ach.img (http://adchoice.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/ach.htm)http://pi.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/a2t.imghttp://pi2.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/487582fc/sc/24/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=V7SSF4wmnXU:I_EXz1cRd9E:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=V7SSF4wmnXU:I_EXz1cRd9E:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=V7SSF4wmnXU:I_EXz1cRd9E:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=V7SSF4wmnXU:I_EXz1cRd9E:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=V7SSF4wmnXU:I_EXz1cRd9E:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/V7SSF4wmnXU
LONDON (Reuters) - AstraZeneca, under pressure from falling sales of older *****, is selling a medicine for a rare type of cancer to Sa**fi as it continues a drive to raise cash by divesting certain assets.
http://rc.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/rc/1/rc.img (http://rc.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/rc/1/rc.htm)
http://rc.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/rc/2/rc.img (http://rc.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/rc/2/rc.htm)
http://rc.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/rc/3/rc.img (http://rc.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/rc/3/rc.htm)
http://da.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/a2.img (http://da.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/a2.htm)
http://adchoice.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/ach.img (http://adchoice.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/ach.htm)http://pi.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/a2t.imghttp://pi2.feedsportal.com/r/234566163523/u/49/f/654207/c/35217/s/487582fc/sc/24/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/487582fc/sc/24/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=V7SSF4wmnXU:I_EXz1cRd9E:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=V7SSF4wmnXU:I_EXz1cRd9E:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=V7SSF4wmnXU:I_EXz1cRd9E:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=V7SSF4wmnXU:I_EXz1cRd9E:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=V7SSF4wmnXU:I_EXz1cRd9E:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/V7SSF4wmnXU